These results suggest that the C-terminal fusion with FLAG-EGFP does not affect the activity of NPC1L1 protein in cholesterol metabolism, which is consistent with previous reports with hepatoma cells in vitro [15, 25]. This evidence concerns the gene NPC1L1 and hepatocellular carcinoma.